Formosa Optical Technology Co.,Ltd. (TPEX:5312)
Taiwan
· Delayed Price · Currency is TWD 145.00
-1.00 (-0.68%)
Feb 21, 2025, 1:30 PM CST
TPEX:5312 Revenue
Formosa Optical Technology had revenue of 1.01B TWD in the quarter ending September 30, 2024, with 2.57% growth. This brings the company's revenue in the last twelve months to 3.97B, up 5.85% year-over-year. In the year 2023, Formosa Optical Technology had annual revenue of 3.86B with 17.16% growth.
Revenue (ttm)
3.97B
Revenue Growth
+5.85%
P/S Ratio
2.19
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.86B | 565.98M | 17.16% |
| Dec 31, 2022 | 3.30B | 384.55M | 13.20% |
| Dec 31, 2021 | 2.91B | -148.72M | -4.86% |
| Dec 31, 2020 | 3.06B | -154.27M | -4.80% |
| Dec 31, 2019 | 3.22B | 150.04M | 4.89% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Pegavision | 7.06B |